LEADER 01260nam0-22003251i-450- 001 990007906700403321 005 20051118145741.0 035 $a000790670 035 $aFED01000790670 035 $a(Aleph)000790670FED01 035 $a000790670 100 $a20040716g19922001km-y0itay50------ba 101 0 $aita 102 $aIT 105 $aabe-----001yy 200 1 $aArcheologia urbana a Savona : scavi e ricerche nel complesso monumentale del Priamàr$fCarlo Varaldo 210 $aBordighera$cIstituto internazionale di studi liguri$d1992-2001 215 $a4 v.$cill.$d30 cm 225 1 $aCollezione di monografie preistoriche ed archeologiche$fIstituto Internazionale di Studi Liguri$v9.$v11. 327 0 $a1.: 1992$a2.: Tavole. 2001$a2.1: Palazzo della Loggia (scavi 1969-1989). 2000$a2.2: Palazzo della Loggia (scavi 1969-1989. I materiali. 2001 610 0 $aScavi archeologici$aSavona 676 $a937.1$v21$zita 700 1$aVaraldo,$bCarlo$0216373 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990007906700403321 952 $a937.1 VAR 1 (1-4)$bBibl. 47679/47680$fFLFBC 959 $aFLFBC 996 $aArcheologia urbana a Savona : scavi e ricerche nel complesso monumentale del Priamàr$9670266 997 $aUNINA LEADER 01279nam--2200397---450- 001 990000929930203316 005 20050822111723.0 010 $a88-464-0716-4 035 $a0092993 035 $aUSA010092993 035 $a(ALEPH)000092993USA01 035 $a0092993 100 $a20020131d1998----km-y0itay0103----ba 101 0 $aita 102 $aIT 105 $ay|||z|||001yy 200 1 $aFormazione, sviluppo organizzativo e gestione delle risorse umane$fa cura di Federico Butera e Michele La Rosa 210 $aMilano$cF. Angeli$dcopyr. 1998 215 $a299 p.$d23 cm 225 2 $aSociologia del lavoro$v64 410 0$12001$aSociologia del lavoro$v65 606 $aSociologia del lavoro 676 $a306.36094 701 1$aLA ROSA,$bMichele$0527330 702 1$aBUTERA,$bFederico$f<1940- > 801 0$aIT$bsalbc$gISBD 912 $a990000929930203316 951 $aII.5. 4432(XV C COLL 9/65)$b161354 L.M.$cXV C COLL$d00079825 959 $aBK 969 $auma 979 $aCHIARA$b90$c20020131$lUSA01$h0952 979 $c20020403$lUSA01$h1736 979 $aPATRY$b90$c20040406$lUSA01$h1704 979 $aCOPAT1$b90$c20050822$lUSA01$h1117 996 $aFormazione, sviluppo organizzativo e gestione delle risorse umane$9972003 997 $aUNISA LEADER 03745nam 22006135 450 001 9910253944103321 005 20200706133441.0 010 $a3-319-65720-8 024 7 $a10.1007/978-3-319-65720-2 035 $a(CKB)4340000000223352 035 $a(DE-He213)978-3-319-65720-2 035 $a(MiAaPQ)EBC5154003 035 $a(PPN)221252630 035 $a(EXLCZ)994340000000223352 100 $a20171122d2017 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aIn Vivo Reprogramming in Regenerative Medicine /$fedited by Açelya Yilmazer 205 $a1st ed. 2017. 210 1$aCham :$cSpringer International Publishing :$cImprint: Humana,$d2017. 215 $a1 online resource (XVII, 103 p. 15 illus. in color.) 225 1 $aStem Cell Biology and Regenerative Medicine,$x2196-8985 311 $a3-319-65719-4 327 $aChapter 1. Introduction to in vivo cell Reprogramming Technology -- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells -- Chapter 3. Direct Reprogramming to Beta Cells -- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration -- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency -- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration -- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology. 330 $aThere have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic. . 410 0$aStem Cell Biology and Regenerative Medicine,$x2196-8985 606 $aRegenerative medicine 606 $aTissue engineering 606 $aStem cells 606 $aCell culture 606 $aTransplantation of organs, tissues, etc 606 $aRegenerative Medicine/Tissue Engineering$3https://scigraph.springernature.com/ontologies/product-market-codes/L16080 606 $aStem Cells$3https://scigraph.springernature.com/ontologies/product-market-codes/L16010 606 $aCell Culture$3https://scigraph.springernature.com/ontologies/product-market-codes/L16020 606 $aTransplant Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59117 615 0$aRegenerative medicine. 615 0$aTissue engineering. 615 0$aStem cells. 615 0$aCell culture. 615 0$aTransplantation of organs, tissues, etc. 615 14$aRegenerative Medicine/Tissue Engineering. 615 24$aStem Cells. 615 24$aCell Culture. 615 24$aTransplant Surgery. 676 $a612.028 676 $a571.538 702 $aYilmazer$b Açelya$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910253944103321 996 $aIn Vivo Reprogramming in Regenerative Medicine$92110405 997 $aUNINA